Determination of tyrosine, tryptophan and their metabolic derivitives by liquid chromatography-electrochemical detection: Application to post mortem samples from patients with Parkinson's and Alzheimer's disease

D. Larry Sparks, John T. Slevin

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Abstract

A procedure is described for the rapid determination of the major indoles and catechols. Analysis with picogram detection limits was done by high-pressure liquid chromatography on a C18 reverse-phase column using electrochemical detection (LCEC). This method provides a comprehensive list of compounds which can be simultaneously determined in brain samples and for which there is no necessity of derivatization or pre-column purification. The regional distribution of 9 neurochemicals from rat brain and the levels of 10 neurochemicals from human brain are presented. DOPA, TYR, NE, MHPG, DOPAC, 5-HIAA, TRP, DA, HVA, 3-MT and 5-HT were detected in the caudate nucleus and putamen. The levels of neurochemicals from the caudate and putamen of a demented patient with Parkinson's disease were variably decreased; catechol and indole losses were greatest in the putamen. The levels of neurochemicals in the caudate and putamen of patients with Alzheimer's disease (SDAT) were also variably decreased; loss of NE was seen only in putamen and losses of DA, HVA and 5-HT were uniform across both caudate and putamen. The CSF of SDAT patients showed changes in NE only.

Original languageEnglish
Pages (from-to)449-457
Number of pages9
JournalLife Sciences
Volume36
Issue number5
DOIs
StatePublished - Feb 4 1985

Funding

FundersFunder number
National Institute on AgingT32AG000084

    ASJC Scopus subject areas

    • General Pharmacology, Toxicology and Pharmaceutics
    • General Biochemistry, Genetics and Molecular Biology

    Fingerprint

    Dive into the research topics of 'Determination of tyrosine, tryptophan and their metabolic derivitives by liquid chromatography-electrochemical detection: Application to post mortem samples from patients with Parkinson's and Alzheimer's disease'. Together they form a unique fingerprint.

    Cite this